Conjugated Linoleic Acid Reduction of Vascular Endothelial Growth Factor Expression in Murine Mammary Tumor Cells through Alteration of Prostaglandin E2

  • Kim, Jung-Hyun (Department of Cell Biology and Human Anatomy, University of California, School of Medicine) ;
  • Hubbard, Neil E. (Department of Cell Biology and Human Anatomy, University of California, School of Medicine) ;
  • Lim, Debora (Department of Cell Biology and Human Anatomy, University of California, School of Medicine) ;
  • Erickson, Kent L. (Department of Cell Biology and Human Anatomy, University of California, School of Medicine)
  • Published : 2006.03.01


Conjugated linoleic acid (CLA) is a group of positional and geometric isomers of linoleic acid that have been used to reduce the incidence, growth and metastasis of breast, colon, prostate and gastric cancer in animals. CLA could reduce tumor growth by altering angiogenesis; a process requiring associated angiogenic factors such as vascular endothelial growth factor (VEGF). In this study, we determined whether CLA could modulate the expression of VEGF in murine mammary tumor cells and adipocytes. The c9, t11-CLA isomer reduced VEGF transcripts and protein when mammary tumor cells were stimulated with PMA. That isomer also reduced VEGF expression in un stimulated mouse 3T3-L1 adipocytes. Since VEGF can be regulated by cyclooxygenase-2 (COX-2), we determined whether CLA could alter COX-2 enzyme expression and $PGE_2$ production. The c9, t11-CLA isomer reduced not only COX-2 enzyme expression but also $PGE_2$ production. Thus, c9, t11-CLA could modulate neovascularization by alteration of VEGF expression from mammary tumor cells and adipocytes by reducing COX-2 metabolites.


  1. Belury MA. 2002. Inhibition of carcinogenesis by conjugated linoleic acid: potential mechanisms of action. J Nutr 132: 2995-2998
  2. Hubbard NE, Lim D, Summers L, Erickson KL. 2000. Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Lett 150: 93-100
  3. Hubbard NE, Lim D, Erickson KL. 2003. Effect of separate conjugated linoleic acid isomers on murine mammary tumor-igenesis. Cancer Lett 190: 13-19
  4. Evans M, Brown J, McIntosh M. 2002. Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism. J Nutr Biochem 13: 508
  5. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, Ramirez RA, Ip MM. 2002. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid. Cancer Res 62: 4383-4389
  6. Folkman J. 1972. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416
  7. Folkman J, Klagsbrun M. 1987. Angiogenic factors. Science 235: 442-447
  8. Hausman GJ, Richardson RL. 2004. Adipose tissue angiogenesis. J Anim Sci 82: 925-934
  9. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D. 2004. Inflammatory cells contribute to the generation of an angiogenic pheno-type in pancreatic ductal adenocarcinoma. J Clin Pathol 57: 630-636
  10. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309
  11. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann W. 2005. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25: 297-310
  12. Stocks J, Bradbury D, Corbett L, Pang L, Knox AJ. 2005.  Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: Role of endogenous prostanoids. FEBS Lett 579: 2551-2556
  13. Mukutmoni M, Hubbard NE, Erickson KL. 2001. Prostaglandin E(2) modulation of vascular endothelial growth factor production in murine macrophages. Prostaglandins Leukot Essent Fatty Acids 65: 123-131
  14. Tevar R, Jho DH, Babcock T, Helton WS, Espat NJ. 2002.  Omega-3 fatty acid supplementation reduces tumor growth and vascular endothelial growth factor expression in a mod-el of progressive non-metastasizing malignancy. JPEN J Parenter Enteral Nutr 26: 285-289
  15. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoe-maker SF, McGee SO, Ip MM. 2004. Isomers of con-jugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr 134: 299-307
  16. Ding YB, Shi RH, Tong JD, Li XY, Zhang GX, Xiao WM, Yang JG, Bao Y, Wu J, Yan ZG, Wang XH. 2005. PGE(2) up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system. Exp Oncol  27: 108-113
  17. Huang SP, Wu MS, Shun CT, Wang HP, Hsieh CY, Kuo ML, Lin JT. 2005. Cyclooxygenase-2 increases hypoxia- induc-ible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci 12: 229-241
  18. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, Tringali G, Navarra P, Ranelletti FO, Palozza P. 2004. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcino-genesis 25: 2303-2310
  19. Mollard RC, Gillam ME, Wood TM, Taylor CG, Weiler HA. 2005. (n-3) fatty acids reduce the release of pros-taglandin E2 from bone but do not affect bone mass in obese (fa/fa) and lean Zucker rats. J Nutr 135: 499-504
  20. Gueck T, Seidel A, Baumann D, Meister A, Fuhrmann H. 2004. Alterations of mast cell mediator production and re-lease by gamma-linolenic and docosahexaenoic acid. Vet Dermatol 15: 309-314
  21. Iwakiri Y, Sampson DA, Allen KG. 2002. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macro-phages. Prostaglandins Leukot Essent Fatty Acids 67: 435-443
  22. Torres-Duarte AP, Vanderhoek JY. 2003. Conjugated linoleic acid exhibits stimulatory and inhibitory effects on pro-stanoid production in human endothelial cells and platelets. Biochim Biophys Acta 1640: 69-76
  23. Park HS, Cho HY, Ha YL, Park JH. 2004. Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem 15: 229-235
  24. Park Y, Pariza MW. 2001. Lipoxygenase inhibitors inhibit heparin-releasable lipoprotein lipase activity in 3T3-L1 adipocytes and enhance body fat reduction in mice by conjugated linoleic acid. Biochim Biophys Acta 1534: 27-33
  25. Kang K, Pariza MW. 2001. trans-10,cis-12-Conjugated linoleic acid reduces leptin secretion from 3T3-L1 adipocytes. Biochem Biophys Res Commun 287: 377-382
  26. Kim JH, Hubbard NE, Ziboh V, Erickson KL. 2005. Conjugated linoleic acid reduction of murine mammary tumor cell growth through 5-hydroxyeicosatetraenoic acid. Biochim Biophys Acta 1687: 103-109
  27. Tsuji M, Murota SI, Morita I. 2003. Docosapentaenoic acid (22:5, n-3) suppressed tube-forming activity in endo-thelial cells induced by vascular endothelial growth factor. Prostaglandins Leukot Essent Fatty Acids 68: 337-342
  28. Zhi YH, Liu RS, Song MM, Tian Y, Long J, Tu W, Guo RX. 2005. Cyclooxygenase-2 promotes angiogenesis by increas-ing vascular endothelial growth factor and predicts progno-sis in gall bladder carcinoma. World J Gastro-enterol 11: 3724-3728
  29. Chang SH, Liu CH, Wu MT, Hla T. 2005. Regulation of vas-cular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the pros-taglandin E2 receptor. Prostaglandins Other Lipid Mediat 76: 48-58
  30. von Rahden BH, Stein HJ, Puhringer F, Koch I, Langer R, Piontek G, Siewert JR, Hofler H, Sarbia M. 2005. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular end-othelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res 65: 5038- 5044
  31. Nakanishi T, Koutoku T, Kawahara S, Murai A, Furuse M. 2003. Dietary conjugated linoleic acid reduces cerebral prosta-glandin E(2) in mice. Neurosci Lett 341: 135-138